Discontinued — last reported Q4 '22
Current Assets
Raw materials
ResMed Raw materials decreased by 6.4% to $350.91M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.3%, from $342.99M to $350.91M. Over 4 years (FY 2021 to FY 2025), Raw materials shows an upward trend with a 24.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ3 2017
Last reportedQ4 2022
Parent metricInventories
How to read this metric
High levels may signal proactive supply chain hedging against shortages, while low levels could indicate lean inventory management or potential supply risks.
Detailed definition
The cost of basic components and supplies held for use in the manufacturing of finished products. This inventory serves...
Peer comparison
Standard across manufacturing sectors; levels vary based on supply chain strategy and lead times.
Metric ID:
inv_raw_materialsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $155.42M | $220.78M | $322.60M | $340.34M | $355.23M | $398.52M | $463.44M | $468.82M | $459.13M | $427.86M | $467.22M | $406.64M | $355.57M | $373.29M | $364.81M | $342.99M | $367.28M | $363.37M | $374.73M | $350.91M |
| QoQ Change | — | +42.1% | +46.1% | +5.5% | +4.4% | +12.2% | +16.3% | +1.2% | -2.1% | -6.8% | +9.2% | -13.0% | -12.6% | +5.0% | -2.3% | -6.0% | +7.1% | -1.1% | +3.1% | -6.4% |
| YoY Change | — | — | — | — | +128.6% | +80.5% | +43.7% | +37.8% | +29.2% | +7.4% | +0.8% | -13.3% | -22.6% | -12.8% | -21.9% | -15.7% | +3.3% | -2.7% | +2.7% | +2.3% |
| % of Inventories | 34.0% | 43.6% | 54.5% | 51.2% | 47.8% | 46.1% | 46.9% | 46.4% | 46.0% | 44.7% | 50.1% | 49.0% | 43.2% | 40.7% | 41.4% | 39.8% | 39.6% | 38.4% | 40.6% | 38.5% |
| Share Change | — | +9.6pp | +10.9pp | -3.3pp | -3.4pp | -1.7pp | +0.8pp | -0.5pp | -0.4pp | -1.4pp | +5.4pp | -1.0pp | -5.8pp | -2.6pp | +0.7pp | -1.6pp | -0.2pp | -1.2pp | +2.2pp | -2.2pp |
Range$155.42M – $468.82M
CAGR+18.7%
Avg YoY Growth+15.5%
Median YoY Growth+2.5%
Raw materials at Other Companies
Frequently Asked Questions
- What is ResMed's raw materials?
- ResMed (RMD) reported raw materials of $350.91M in Q1 2026.
- How has ResMed's raw materials changed year-over-year?
- ResMed's raw materials increased by 2.3% year-over-year, from $342.99M to $350.91M.
- What is the long-term trend for ResMed's raw materials?
- Over 4 years (2021 to 2025), ResMed's raw materials has grown at a 24.0% compound annual growth rate (CAGR), from $155.42M to $367.28M.
- What does raw materials mean?
- The value of basic materials and supplies waiting to be used in production.